AFJKU Company Profile and Key Details

The stock is currently mid-range between its 52-week high and low $7.60 and $80.00. With a market capitalization of about $294.56 million, Aimei Health Technology Co., Ltd Unit is classified as a micro-cap and shows lower-than-market volatility (beta ~-1.50). Key stats such as the average daily volume over the past year has been around 75.00 shares, volume is running light vs its 52-week average. Headquartered in New York City, None, Aimei Health Technology Co., Ltd Unit operates in the Financial Services sector and the Shell Companies industry. Led by CEO Junheng Xie, the company employs approximately 2 people and listed since December 04, 2023. Aimei Health Technology Co Ltd is a blank check company.

Average 10-day trading volume of 409.67 shares is significantly above the 3-month average of 155.26, indicating heightened recent market interest.

Aimei Health Technology Co., Ltd Unit last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.02. This means the shares are trading below this model’s fair value.

Our AI price prediction model suggests that Aimei Health Technology Co., Ltd Unit stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Valuation shows Aimei Health Technology Co., Ltd Unit trading at a premium to the broader market with a P/E of 146.38.

Aimei Health Technology Co., Ltd Unit trades at a P/E ratio of 146.38, slightly above the S&P 500 average, with a price-to-sales ratio of 0.0 and a price-to-book ratio of 4.9 trading at moderately above to book value. The P/FCF stands at -439.71, also below market averages.